Michael Thomas Heffernan, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 50,000 shares at $18.12 ($909K) on 2018-12-17, disclosed to the SEC on 2018-12-18.
Open-market sale of $909k COLL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.12 | 21,687 | $393K | 43.2% |
| 2 | $18.12 | 21,687 | $393K | 43.2% |
| 3 | $18.57 | 3,313 | $62K | 6.8% |
| 4 | $18.57 | 3,313 | $62K | 6.8% |
| Total | $18.18 avg | 50,000 | $909K | 100% |
| Filing → |
| COLL | SELL | 2022-12-14 | $8.4M | — | Filing → |
| COLL | SELL | 2021-03-17 | $2.5M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |